Zdrowie i gospodarka · 07/10/2008
FDA Corrects Withdrawal of Approval for 128 Suitability Petitions
The FDA is correcting a notice that withdrew approval of 128 suitability petitions, including one submitted by Roxane Laboratories for lorazepam oral solution, and retroactively reinstates its approval for that petition due to errors in the petition numbers.